For example, acute promyelocytic leukemia (APL) exhibits a characteristic immunophenotype (CD34−, HLA-DR−, CD117+, CD15−) that can prompt PML::RARA gene fusion evaluation and consequent management until the molecular result is available. The gene discussed is KIT; the disease is acute promyelocytic leukemia.